No one knows about this stock. That's unfortunate. They have potential to be a game changer if any major hospitals start to use or endorse the PURE EP system. I would think many more would follow. With recent FDA approval, it should be only a matter of time before it gets some mainstream press. This seems like a sleeper.
BioSig Technologies Inc. (BSGM) is a medical device company engaged in the development and commercialization of a proprietary signal processing platform designed to significantly improve real-time information and clinical decision-making in the ~$4B - $5B electrophysiology (EP) market. Their PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System is a signal acquisition and processing system used by electrophysiologists during cardiac ablation procedures to help identify areas of tissue that create an abnormal heart rhythm (arrhythmia).